Turmeric Acquisition announced that holders of the units sold in the company’s IPO may trade them separately starting today. Units not separated will continue to trade on the Nasdaq under “TMPM.U,” and the separated shares and warrants will trade under “TMPM” and “TMPM.W,” respectively. The SPAC is targeting the healthcare sector. Read more.
Related Posts
Carney Technology II Files Underwriting Purchase of 35M Shares
The tech SPAC in a filing said it plans to sell 35 million unites to Morgan Stanley, Cantor Fitzgerald and Mizuho
Novus Files Prelim Proxy on AppHarvest Deal
The SPAC in an S-4 filing indicated it expects a shareholder vote on the $532.2 million deal with AppHarvest by year's end.
POINT Biopharma Merging With Research Alliance I at $924M Valuation
The combined company is expected to receive net proceeds of approximately $300 million at the closing of the transaction, including a $165 million PIPE.
Dragoneer Amends $200M IPO
The SPAC's first amendement to its prospectus includes details on private placements, the shareholder rights agreement and consent of counsel.